A determination of the pre-analytical storage conditions for insulin like growth factor-I and type III procollagen peptide

Growth Hormone and IGF Research

Volumn 19, Issue 1, 2009, Pages 43-50

  Holt, Richard I G ^a   Erotokritou Mulligan, Ioulietta ^a   Ridley, Sean A ^a   McHugh, Cathy M ^a   Bassett, E Eryl ^b   Cowan, David A ^c   Bartlett, Christiaan ^c   Sönksen, Peter H ^a  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^b UNIVERSITY OF KENT   (United Kingdom)

^c KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Doping; GH abuse; IGF I; Pre analytical conditions; Procollagen type III

Indexed keywords

EDETIC ACID; HEPARIN; PROCOLLAGEN TYPE 3 AMINOPROPEPTIDE; SOMATOMEDIN C;

ADULT; ARTICLE; CENTRIFUGATION; CONTROLLED STUDY; DOPING; FEMALE; HUMAN; MALE; NORMAL HUMAN; OBSERVATIONAL STUDY; PRIORITY JOURNAL; ROOM TEMPERATURE; STORAGE TEMPERATURE; TEMPERATURE DEPENDENCE; UNITED KINGDOM; VOLUNTEER;

BLOOD PRESERVATION; BLOOD SPECIMEN COLLECTION; COLLAGEN TYPE III; EDETIC ACID; HEPARIN; HUMANS; INSULIN-LIKE GROWTH FACTOR I; TEMPERATURE;

EID: 58949086794     PISSN: 10966374     EISSN: 15322238     Source Type: Journal    
DOI: 10.1016/j.ghir.2008.06.001     Document Type: Article

References (12)

1. Powrie J.K., Bassett E.E., Rosen T., Jorgensen J.O., Napoli R., Sacca L., Christiansen J.S., Bengtsson B.A., and Sonksen P.H. Detection of growth hormone abuse in sport. Growth Horm. IGF Res. 17 3 (2007) 220-226
2. Zhang D.J., Elswick R.K., Miller W.G., and Bailey J.L. Effect of serum-clot contact time on clinical chemistry laboratory results. Clin. Chem. 44 6 Pt. 1 (1998) 1325-1333
3. Kubasik N.P., Ricotta M., Hunter T., and Sine H.E. Effect of duration and temperature of storage on serum analyte stability: examination of 14 selected radioimmunoassay procedures. Clin. Chem. 28 1 (1982) 164-165
4. Livesey J.H., Hodgkinson S.C., Roud H.R., and Donald R.A. Effect of time, temperature and freezing on the stability of immunoreactive LH, FSH, TSH, growth hormone, prolactin and insulin in plasma. Clin. Biochem. 13 4 (1980) 151-155
5. Evans M.J., Livesey J.H., Ellis M.J., and Yandle T.G. Effect of anticoagulants and storage temperatures on stability of plasma and serum hormones. Clin. Biochem. 34 2 (2001) 107-112
6. Hankinson S.E., Willett W.C., Colditz G.A., Hunter D.J., Michaud D.S., Deroo B., Rosner B., Speizer F.E., and Pollak M. Circulating concentrations of insulin-like growth factor-I and risk of breast cancer. Lancet 351 9113 (1998) 1393-1396
7. Jane Ellis M., Livesey J.H., and Evans M.J. Hormone stability in human whole blood. Clin. Biochem. 36 2 (2003) 109-112
8. Kristal A.R., King I.B., Albanes D., Pollak M.N., Stanzyk F.Z., Santella R.M., and Hoque A. Centralized blood processing for the selenium and vitamin E cancer prevention trial: effects of delayed processing on carotenoids, tocopherols, insulin-like growth factor-I, insulin-like growth factor binding protein 3, steroid hormones, and lymphocyte viability. Cancer Epidem. Biomar. 14 3 (2005) 727-730
9. Harris T.G., Strickler H.D., Yu H., Pollak M.N., Monrad E.S., Travin M.I., Xue X., Rohan T.E., and Kaplan R.C. Specimen processing time and measurement of total insulin-like growth factor-I (IGF-I), free IGF-I, and IGF binding protein-3 (IGFBP-3). Growth Horm. IGF Res. 16 2 (2006) 86-92
10. Yu H., Mistry J., Nicar M.J., Khosravi M.J., Diamandis A., van Doorn J., and Juul A. Insulin-like growth factors (IGF-I, free IGF-I and IGF-II) and insulin-like growth factor binding proteins (IGFBP-2, IGFBP-3, IGFBP-6, and ALS) in blood circulation. J. Clin. Lab. Anal. 13 4 (1999) 166-172
11. Renehan A.G., Jones J., O'Dwyer S.T., and Shalet S.M. Determination of IGF-I, IGF-II, IGFBP-2, and IGFBP-3 levels in serum and plasma: comparisons using the Bland-Altman method. Growth Horm. IGF Res. 13 6 (2003) 341-346
12. World Anti-Doping Agency, International Standard for Laboratories Ver 5.0, January 2008. .